Insider Transactions in Q3 2017 at Abbott Laboratories (ABT)
Insider Transaction List (Q3 2017)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 26
2017
|
Daniel Gesua Sive Salvadori EXECUTIVE VICE PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
5,487
-6.92%
|
$285,324
$52.61 P/Share
|
|
Sep 26
2017
|
Daniel Gesua Sive Salvadori EXECUTIVE VICE PRESIDENT |
SELL
Open market or private sale
|
Direct |
62,460
-44.07%
|
$3,247,920
$52.95 P/Share
|
|
Sep 26
2017
|
Daniel Gesua Sive Salvadori EXECUTIVE VICE PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
62,460
+19.89%
|
$2,748,240
$44.54 P/Share
|
|
Sep 22
2017
|
Jaime Contreras Senior Vice President |
SELL
Open market or private sale
|
Direct |
52,700
-5.69%
|
$2,740,400
$52.0 P/Share
|
|
Sep 22
2017
|
Jaime Contreras Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
52,700
+18.48%
|
$1,317,500
$25.2 P/Share
|
|
Aug 16
2017
|
Stephen R Fussell Executive Vice President |
SELL
Open market or private sale
|
Direct |
196,550
-51.9%
|
$9,630,950
$49.5 P/Share
|
|
Aug 16
2017
|
Stephen R Fussell Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
196,550
+11.9%
|
$4,913,750
$25.67 P/Share
|
|
Aug 14
2017
|
Edward M Liddy Director |
BUY
Open market or private purchase
|
Direct |
1,185
+4.91%
|
$56,880
$48.96 P/Share
|
|
Aug 02
2017
|
Daniel J Starks |
BUY
Exercise of conversion of derivative security
|
Direct |
504,544
+3.55%
|
$15,136,320
$30.82 P/Share
|
|
Aug 01
2017
|
Sharon J Bracken Senior Vice President |
SELL
Open market or private sale
|
Direct |
2,000
-2.33%
|
$98,000
$49.16 P/Share
|
|
Jul 27
2017
|
Brian J Blaser Executive Vice President |
SELL
Open market or private sale
|
Direct |
15,000
-9.48%
|
$750,000
$50.0 P/Share
|
|
Jul 25
2017
|
Hubert L Allen EXECUTIVE VICE PRESIDENT |
SELL
Open market or private sale
|
Direct |
4,600
-1.47%
|
$230,000
$50.79 P/Share
|
|
Jul 25
2017
|
Hubert L Allen EXECUTIVE VICE PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
4,600
+4.18%
|
$119,600
$26.7 P/Share
|
|
Jul 24
2017
|
Charles Brynelsen SENIOR VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
9,980
+50.0%
|
-
|
|
Jul 21
2017
|
Daniel Gesua Sive Salvadori EXECUTIVE VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
7,173
+8.3%
|
-
|
|
Jul 21
2017
|
Michael J Pederson SENIOR VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
16,028
+11.41%
|
-
|
|
Jul 21
2017
|
Eric S Fain Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
28,012
-2.58%
|
$1,400,600
$50.84 P/Share
|
|
Jul 10
2017
|
Sharon J Bracken Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
5,167
+15.03%
|
-
|
|
Jul 07
2017
|
Michael T Rousseau Pres., Cardiovas. & Neuromod. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,288
-1.76%
|
$157,824
$48.44 P/Share
|
|
Jul 04
2017
|
Daniel J Starks |
SELL
Payment of exercise price or tax liability
|
Direct |
24,236
-0.38%
|
$1,163,328
$48.71 P/Share
|
|
Jul 01
2017
|
Robert B Ford CHAIRMAN AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,618
-3.01%
|
$77,664
$48.61 P/Share
|
|
Jul 01
2017
|
Heather L Mason Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
613
-1.03%
|
$29,424
$48.61 P/Share
|